目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONAL SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
FIGURE 4 PRODUCT-BASED MARKET ESTIMATION
2.2.2 APPLICATION-BASED MARKET ESTIMATION
FIGURE 5 APPLICATION-BASED MARKET ESTIMATION
2.3 PRIMARY RESEARCH VALIDATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
FIGURE 7 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 38)
FIGURE 8 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 10 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 REGIONAL SNAPSHOT OF NGS-BASED RNA-SEQUENCING MARKET

4 PREMIUM INSIGHTS (Page No. - 42)
4.1 NGS-BASED RNA-SEQUENCING MARKET OVERVIEW
FIGURE 13 GROWING RESEARCH ACTIVITIES INVOLVING RNA-SEQUENCING TO DRIVE MARKET
4.2 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END USER AND COUNTRY (2021)
FIGURE 14 CHINA TO DOMINATE ASIA PACIFIC MARKET IN 2021
4.3 GEOGRAPHICAL SNAPSHOT OF NGS-BASED RNA-SEQUENCING MARKET
FIGURE 15 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 NGS-BASED RNA-SEQUENCING MARKET, BY REGION
FIGURE 16 NORTH AMERICA TO DOMINATE NGS-BASED RNA-SEQUENCING MARKET IN 2027

5 MARKET OVERVIEW (Page No. - 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 NGS-BASED RNA-SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Decreasing costs of genome sequencing
FIGURE 18 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2021
5.2.1.2 Advantages of RNA-sequencing over conventional technologies
5.2.1.3 Increasing government funding to support genomics projects
5.2.1.4 Growing research involving RNA-sequencing
5.2.1.5 Rising cancer cases and increasing applications of NGS in cancer research
TABLE 1 CANCER INCIDENCE, 2020 VS. 2040
5.2.1.6 Rapid growth in personalized medicine adoption
5.2.2 RESTRAINTS
5.2.2.1 Lack of qualified specialists
5.2.2.2 End-user budget constraints in developing countries
5.2.2.3 Standardization concerns of RNA-sequencing in diagnostic testing
5.2.3 OPPORTUNITIES
5.2.3.1 Adoption of blockchain technology and cloud computing
5.2.4 CHALLENGES
5.2.4.1 Storage and interpretation of sequencing data
5.2.4.2 Analysis of RNA-sequencing data to detect novel transcripts
5.2.4.3 Ethical issues and challenges in testing procedure

6 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE (Page No. - 55)
6.1 INTRODUCTION
TABLE 2 NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
6.2 RNA-SEQUENCING PLATFORMS & CONSUMABLES
6.2.1 INCREASING AVAILABILITY OF PLATFORMS AND GROWING CONSUMABLE USAGE TO ENSURE GROWTH
TABLE 3 RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 4 NORTH AMERICA: RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 5 EUROPE: RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 6 ASIA PACIFIC: RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 LATIN AMERICA: RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY REGION, 2020-2027 (USD MILLION)
6.3 SAMPLE PREPARATION PRODUCTS
6.3.1 SAMPLE PREPARATION TO BE FIRST STEP OF NGS WORKFLOW
TABLE 8 SAMPLE PREPARATION PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: SAMPLE PREPARATION PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 10 EUROPE: SAMPLE PREPARATION PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 11 ASIA PACIFIC: SAMPLE PREPARATION PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 12 LATIN AMERICA: SAMPLE PREPARATION PRODUCTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.3.2 SAMPLE PREPARATION PRODUCTS, BY WORKFLOW
6.3.2.1 Library preparation & target enrichment
6.3.2.2 Quality control
6.3.3 SAMPLE PREPARATION PRODUCTS, BY METHOD
6.3.3.1 Manual sample preparation
6.3.3.2 Microfluidic sample preparation
6.3.3.3 Robotic liquid handling sample preparation
6.4 RNA-SEQUENCING SERVICES
6.4.1 INCREASING ADOPTION OF ADVANCED INFRASTRUCTURE AND EXPERTISE AMONG END USERS TO DRIVE DEMAND
TABLE 13 RNA-SEQUENCING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 14 NORTH AMERICA: RNA-SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 15 EUROPE: RNA-SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 16 ASIA PACIFIC: RNA-SEQUENCING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: RNA-SEQUENCING PLATFORMS & CONSUMABLES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
6.5 DATA ANALYSIS, STORAGE & MANAGEMENT
6.5.1 INTEGRATION OF CLOUD COMPUTING AND BIOINFORMATICS TO PROPEL MARKET
TABLE 18 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 19 NORTH AMERICA: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 21 ASIA PACIFIC: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 22 LATIN AMERICA: DATA ANALYSIS, STORAGE & MANAGEMENT MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY (Page No. - 69)
7.1 INTRODUCTION
TABLE 23 NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
7.2 SEQUENCING BY SYNTHESIS
7.2.1 SBS TECHNOLOGY TO ENABLE HIGHEST PRODUCTION OF BASE PAIRS WITHIN SHORTEST TIME
TABLE 24 SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 25 NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 26 EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 27 ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 28 LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.3 ION SEMICONDUCTOR SEQUENCING
7.3.1 ION SEMICONDUCTOR SEQUENCING PLATFORMS TO POSSESS HIGH-THROUGHPUT CAPABILITIES
TABLE 29 ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 30 NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 31 EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 32 ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 33 LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.4 SINGLE-MOLECULE REAL-TIME SEQUENCING
7.4.1 SMRT SEQUENCING TO PRODUCE RESULTS IN SHORTER TIME AND LOWER COSTS
TABLE 34 SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 35 NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 36 EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 37 ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 38 LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
7.5 NANOPORE SEQUENCING
7.5.1 NANOPORE SEQUENCING TO POSSESS DIRECT RNA-SEQUENCING CAPABILITIES
TABLE 39 NANOPORE SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 40 NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 41 EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 42 ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 43 LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION (Page No. - 83)
8.1 INTRODUCTION
TABLE 44 NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.2 EXPRESSION PROFILING ANALYSIS
8.2.1 INCREASING NEED FOR IMPROVED PROGNOSIS OF PATIENTS TO PROPEL MARKET
TABLE 45 EXPRESSION PROFILING ANALYSIS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 46 NORTH AMERICA: EXPRESSION PROFILING ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 47 EUROPE: EXPRESSION PROFILING ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 48 ASIA PACIFIC: EXPRESSION PROFILING ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 49 LATIN AMERICA: EXPRESSION PROFILING ANALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.3 SMALL RNA-SEQUENCING
8.3.1 RISING NEED FOR ACCURATE DIAGNOSTIC ANALYSIS TO SUPPORT MARKET
TABLE 50 SMALL RNA-SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 51 NORTH AMERICA: SMALL RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 52 EUROPE: SMALL RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: SMALL RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 54 LATIN AMERICA: SMALL RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.4 DE NOVO TRANSCRIPTOME ASSEMBLY
8.4.1 INCREASING CANCER CASES TO DRIVE SEGMENT
TABLE 55 DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 56 NORTH AMERICA: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 57 EUROPE: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 58 ASIA PACIFIC: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 59 LATIN AMERICA: DE NOVO TRANSCRIPTOME ASSEMBLY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
8.5 VARIANT CALLING & TRANSCRIPTOME EPIGENETICS
8.5.1 COMPLICATED RNA SEQUENCE DATA ANALYSIS TO RESTRAIN SEGMENT
TABLE 60 VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 61 NORTH AMERICA: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 62 EUROPE: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 63 ASIA PACIFIC: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
TABLE 64 LATIN AMERICA: VARIANT CALLING & TRANSCRIPTOME EPIGENETICS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

9 NGS-BASED RNA-SEQUENCING MARKET, BY END USER (Page No. - 96)
9.1 INTRODUCTION
TABLE 65 NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)
9.2 RESEARCH & ACADEMIA
9.2.1 INCREASING COLLABORATIONS WITH NGS PLAYERS AND RISING GOVERNMENT FUNDING TO PROPEL MARKET
TABLE 66 NGS-BASED RNA-SEQUENCING MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2020-2027 (USD MILLION)
9.3 HOSPITALS & CLINICS
9.3.1 INCREASING ADOPTION OF NGS SYSTEMS TO DRIVE MARKET
TABLE 67 NGS-BASED RNA-SEQUENCING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2027 (USD MILLION)
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4.1 CONSOLIDATION WITH NGS PLAYERS FOR TARGET THERAPIES TO PROPEL MARKET
TABLE 68 NGS-BASED RNA-SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2027 (USD MILLION)
9.5 OTHER END USERS
TABLE 69 NGS-BASED RNA-SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2020-2027 (USD MILLION)

10 NGS-BASED RNA-SEQUENCING MARKET, BY REGION (Page No. - 102)
10.1 INTRODUCTION
TABLE 70 NGS-BASED RNA-SEQUENCING MARKET, BY REGION, 2020-2027(USD MILLION)
10.2 NORTH AMERICA
FIGURE 19 NORTH AMERICA: MARKET SNAPSHOT
TABLE 71 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027(USD MILLION)
TABLE 72 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 73 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 74 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 75 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027(USD MILLION)
10.2.1 US
10.2.1.1 Favorable funding scenario and growing R&D activity to drive market
TABLE 76 US: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 77 US: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 78 US: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives for genome research to boost market
TABLE 79 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 80 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 81 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.3 EUROPE
TABLE 82 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027(USD MILLION)
TABLE 83 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 84 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 85 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 86 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027(USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European market during forecast period
TABLE 87 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 88 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 89 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.3.2 UK
10.3.2.1 Strong presence of NGS organizations and their initiatives to stimulate market
TABLE 90 UK: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 91 UK: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 92 UK: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.3.3 FRANCE
10.3.3.1 Growing awareness of high-throughput sequencing in genetic characterization to accelerate growth
TABLE 93 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 94 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 95 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.3.4 REST OF EUROPE
TABLE 96 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 97 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 98 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.4 ASIA PACIFIC
FIGURE 20 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 99 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027(USD MILLION)
TABLE 100 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 101 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 102 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 103 ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027(USD MILLION)
10.4.1 CHINA
10.4.1.1 Established players and favorable government initiatives to drive market
TABLE 104 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 105 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 106 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.4.2 JAPAN
10.4.2.1 Growing awareness and rising incidence of genetic disorders to propel market
TABLE 107 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 108 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 109 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising interest of companies for collaborations to drive market
TABLE 110 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 111 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 112 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 113 REST OF ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 114 REST OF ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 115 REST OF ASIA PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.5 LATIN AMERICA
TABLE 116 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY COUNTRY, 2020-2027(USD MILLION)
TABLE 117 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 118 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 119 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 120 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027(USD MILLION)
10.5.1 BRAZIL
10.5.1.1 High HIV prevalence to drive demand for NGS in research
TABLE 121 BRAZIL: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 122 BRAZIL: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 123 BRAZIL: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.5.2 MEXICO
10.5.2.1 Economic growth and support for infrastructural development to propel market
TABLE 124 MEXICO: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 125 MEXICO: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 126 MEXICO: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 127 REST OF LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 128 REST OF LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 129 REST OF LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 LACK OF INFRASTRUCTURE TO RESTRAIN MARKET
TABLE 130 MIDDLE EAST & AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020-2027(USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2020-2027(USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2020-2027(USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY END USER, 2020-2027(USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 143)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 21 KEY DEVELOPMENTS IN NGS-BASED RNA-SEQUENCING MARKET, 2019-2022
11.3 MARKET SHARE ANALYSIS
FIGURE 22 NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 134 NGS-BASED RNA-SEQUENCING MARKET: DEGREE OF COMPETITION
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.5 COMPETITIVE LEADERSHIP MAPPING
11.5.1 TERMINOLOGY/NOMENCLATURE
11.5.1.1 Visionary leaders
11.5.1.2 Innovators
11.5.1.3 Dynamic differentiators
11.5.1.4 Emerging companies
FIGURE 24 NGS-BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2021 (OVERALL MARKET)
FIGURE 25 NGS-BASED RNA-SEQUENCING MARKET, COMPETITIVE LEADERSHIP MAPPING, 2021 (SMES/START-UPS)
11.6 COMPETITIVE SCENARIO
TABLE 135 NGS-BASED RNA-SEQUENCING MARKET: PRODUCT/SERVICE LAUNCHES
TABLE 136 NGS-BASED RNA-SEQUENCING MARKET: DEALS
TABLE 137 NGS-BASED RNA-SEQUENCING MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 151)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
12.1 KEY PLAYERS
12.1.1 ILLUMINA, INC.
TABLE 138 ILLUMINA, INC.: COMPANY OVERVIEW
FIGURE 26 ILLUMINA, INC.: COMPANY SNAPSHOT, 2021
TABLE 139 ILLUMINA, INC.: PRODUCT LAUNCHES
TABLE 140 ILLUMINA, INC.: DEALS
TABLE 141 ILLUMINA, INC.: OTHER DEVELOPMENTS
12.1.2 QIAGEN N.V.
TABLE 142 QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT, 2021
TABLE 143 QIAGEN N.V.: PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 144 QIAGEN N.V.: DEALS
12.1.3 PERKINELMER, INC.
TABLE 145 PERKINELMER, INC.: COMPANY OVERVIEW
FIGURE 28 PERKINELMER, INC.: COMPANY SNAPSHOT, 2021
TABLE 146 PERKINELMER, INC.: PRODUCT LAUNCHES
12.1.4 EUROFINS SCIENTIFIC
TABLE 147 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
FIGURE 29 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT, 2021
TABLE 148 EUROFINS SCIENTIFIC: DEALS
12.1.5 OXFORD NANOPORE TECHNOLOGIES
TABLE 149 OXFORD NANOPORE TECHNOLOGIES: COMPANY OVERVIEW
TABLE 150 OXFORD NANOPORE TECHNOLOGIES: PRODUCT LAUNCHES
TABLE 151 OXFORD NANOPORE TECHNOLOGIES: DEALS
TABLE 152 OXFORD NANOPORE TECHNOLOGIES: OTHER DEVELOPMENTS
12.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 153 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT, 2021
12.1.7 BGI GROUP
TABLE 154 BGI GROUP: COMPANY OVERVIEW
TABLE 155 BGI GROUP: DEALS
12.1.8 GENEWIZ (PART OF BROOKS AUTOMATION)
TABLE 156 GENEWIZ: COMPANY OVERVIEW
TABLE 157 GENEWIZ: SERVICES LAUNCHED
12.1.9 HAMILTON COMPANY
TABLE 158 HAMILTON COMPANY: COMPANY OVERVIEW
12.1.10 NUGEN TECHNOLOGIES (PART OF TECAN TRADING AG)
TABLE 159 NUGEN TECHNOLOGIES: COMPANY OVERVIEW
12.1.11 PSOMAGEN (FORMERLY KNOWN AS MACROGEN)
TABLE 160 PSOMAGEN: COMPANY OVERVIEW
12.1.12 F. HOFFMANN-LA ROCHE AG
TABLE 161 F. HOFFMANN-LA ROCHE AG: COMPANY OVERVIEW
FIGURE 31 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT, 2021
TABLE 162 F. HOFFMANN-LA ROCHE AG: DEALS
12.1.13 THERMO FISHER SCIENTIFIC, INC.
TABLE 163 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT, 2021
TABLE 164 THERMO FISHER SCIENTIFIC, INC.: DEALS
12.1.14 TAKARA BIO, INC.
TABLE 165 TAKARA BIO, INC.: COMPANY OVERVIEW
FIGURE 33 TAKARA BIO, INC.: COMPANY SNAPSHOT, 2021
12.1.15 PACIFIC BIOSCIENCES
TABLE 166 PACIFIC BIOSCIENCES: COMPANY OVERVIEW
FIGURE 34 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT, 2021
12.2 OTHER PLAYERS
12.2.1 ZYMO RESEARCH
12.2.2 LUCIGEN CORPORATION
12.2.3 GENOTYPIC TECHNOLOGY
12.2.4 OXFORD GENE TECHNOLOGY (PART OF SYSMEX)
12.2.5 BECTON, DICKINSON AND COMPANY
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 201)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS